World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases

Hale Capital Management announces the successful close of Hale Capital Partners Fund V, increasing assets under management to $334 million

Cision PR Newswire by Cision PR Newswire
December 19, 2025
in Press Releases
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

NEW YORK, Dec. 19, 2025 /PRNewswire/ — Hale Capital Management (“Hale Capital”) announces the successful close of Hale Capital Partners Fund V (“Fund V”), increasing assets under management to $334 million. Fund V supports Hale Capital’s long-standing strategy of partnering with management teams and boards to build, scale, and reinvent lower-middle-market national security and technology businesses at critical operating and growth inflection points.


Hale Capital Partners (PRNewsfoto/Hale Capital Partners)

Hale Capital is a US-based investment firm investing across two clearly defined lanes.

In federal technology and services, Hale Capital targets significant minority to control positions in businesses serving the defense and intelligence community. These investments are anchored by durable end-user demand, mission-critical products, and long-term customer relationships. Hale Capital also invests selectively in defense-related laboratory spinouts, partnering with founding teams to help translate proven research into scalable, mission-ready platforms.

In commercial technology, Hale Capital focuses on reinventions – often in public companies or complex carve-outs – where strong leadership teams and experienced capital partners can catalyze the next product cycle while restoring or accelerating profitability. These investments center on attracting stellar talent, sharpening product focus, and building offerings that reposition the business for durable, cash-generative growth. Hale Capital works closely with management and boards to align product strategy, cost structure, and capital allocation with a deep operating playbook and decades of successful technology reinventions.

Across both lanes, Hale Capital’s approach is built on deep trust and long-duration partnerships with management teams, boards, and government stakeholders. The firm is a DoD Trusted Investor, with active Top Secret clearances across its investment team, and maintains longstanding relationships across the defense, intelligence, and advanced research ecosystem.

About Hale Capital:

Hale Capital is a US-based investment firm that partners with exceptional leaders to create enduring national security and technology businesses. The firm invests where differentiated products, talented teams, and clear end-user demand converge with disciplined execution and profitability.

Hale Capital’s value creation approach emphasizes collaboration, talent augmentation, and hands-on operational engagement, supported by a repeatable operating playbook refined through decades of investing across public and private markets.

For more information, visit www.halecapital.com.

Media Contacts:
Hale Capital Management
Nathan Foos
nate@halefunds.com
www.halecapital.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/hale-capital-management-announces-the-successful-close-of-hale-capital-partners-fund-v-increasing-assets-under-management-to-334-million-302647192.html

SOURCE Hale Capital Partners

Cision PR Newswire

Cision PR Newswire

Related Posts

Yili Shares China’s Whole-Value-Chain Dairy Symbiosis Model at FAO Global Conference

September 28, 2026

Ancient Wushu Meets AIGC: How Cangzhou Is Reimagining Its Cultural Story

September 28, 2026

Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer

September 28, 2026

Poseidon Capital Partners appoints Premialab to strengthen QIS-driven portfolio construction

September 28, 2026

Innovent Announces Expansion of Global Phase 3 MarsLight-11 Study of IBI363/TAK-928 (Alpha-biased IL-2/PD-1 Bispecific Fusion Protein) in Immunotherapy-Resistant NSCLC to Include Patients with Non-Squamous NSCLC

September 28, 2026

SEEKOUT Moves Beyond Japan into North America and Europe, Accelerating Global Push in Premium Pet Market

September 28, 2026

Popular News

  • Yili Shares China’s Whole-Value-Chain Dairy Symbiosis Model at FAO Global Conference

    0 shares
    Share 0 Tweet 0
  • Ancient Wushu Meets AIGC: How Cangzhou Is Reimagining Its Cultural Story

    0 shares
    Share 0 Tweet 0
  • Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer

    0 shares
    Share 0 Tweet 0
  • Poseidon Capital Partners appoints Premialab to strengthen QIS-driven portfolio construction

    0 shares
    Share 0 Tweet 0
  • PAINSTUDY Inc. Targets ‘Self-Medication’ Demand with Functional Muscle and Joint Patches

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler